. The company’s pipeline contains 4 scientific-stage therapies. Its most State-of-the-art drug applicant is ROS1 inhibitor taletrectinib for managing lung cancer. Nuvation is completing two period two pivotal scientific studies on taletrectinib.May well thirteen – Musk tweets that the Twitter offer is "temporarily on maintain," ??citing problem